ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #7,807Hybrid

Enzyme and Microbial Technology

Acronym:enzmictec
•
Abbreviation (ISO):ENZYME MICROB. TECHNOL
•
Identifier (ISSN):0141-0229(Print)/1879-0909(Online)
•
Publisher:Elsevier Inc.
Clarivate IF (2026)
3.9↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Enzyme and Microbial Technology

WoS Q2
23452.9320183.5520193.4520203.4920213.7120223.420233.420243.720253.92026
Annual Impact Factor Metric
Current (2026):3.9
Scopus SJR & RankScopus Q2
0.731
#7,807

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
171

171 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate5.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
165articles/year
13.84% Gold OA•96.6% Original Research

Aims & Scope

Enzyme and Microbial Technology is an international, peer-reviewed journal publishing original research and reviews, of biotechnological significance and novelty, on basic and applied aspects of the science and technology of processes involving the use of enzymes, micro-organisms, animal cells and plant cells. We especially encourage submissions on: Biocatalysis and the use of Directed Evolution in Synthetic Biology and Biotechnology Biotechnological Production of New Bioactive Molecules, Biomaterials, Biopharmaceuticals, and Biofuels New Imaging Techniques and Biosensors, especially as applicable to Healthcare and Systems Biology New Biotechnological Approaches in Genomics, Proteomics and Metabolomics Metabolic Engineering, Biomolecular Engineering and Nanobiotechnology Manuscripts which report isolation, purification, immobilization or utilization of organisms or enzymes which are already well-described in the literature are not suitable for publication in EMT, unless their primary purpose is to report significant new findings or approaches which are of broad biotechnological importance. Similarly, manuscripts which report optimization studies on well-established processes are inappropriate. EMT does not accept papers dealing with mathematical modeling unless they report significant, new experimental data.

Topics Covered (Recognized by AI)
Biology85.6%Chemistry84.8%Biochemistry79.6%Organic chemistry76.7%Physics70.1%Nuclear magnetic resonance57.9%Enzyme56.5%Genetics54.5%Medicine47%Geology34.3%Food science32.2%Engineering31.4%Chromatography30.7%Gene29.4%Materials science27.1%Paleontology25.3%Ecology23.3%Pathology23.3%Quantum mechanics21.6%Botany21.3%Chemical engineering20.7%Bacteria20.2%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q2
Rank75/180
IndexSCIE
JCISCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q2
Rank63/180
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.9
Articles / Year111
Total Citations32
2025
IF3.7
Articles / Year165
Total Citations370
2024
IF3.4
Articles / Year118
Total Citations764
2023
IF3.4
Articles / Year135
Total Citations1,526
2022
IF3.705
Articles / Year147
Total Citations2,459

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,807Scopus Q2SCImago Profile
Scopus Coverage:1979-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyChemical EngineeringImmunology and Microbiology
Scopus Citation Rank (SJR)Q2
0.731

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
4.34

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,088 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,684
3-Year Documents384
Citable Documents384

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Applied Microbiology and BiotechnologyQ2
BiochemistryQ2
BioengineeringQ2
BiotechnologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Biology
Minor Category (Specific Field):
3区BIOTECHNOLOGY & APPLIED MICROBIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Enzyme and Microbial Technology (acronym: enzmictec, abbr: ENZYME MICROB. TECHNOL, ISSN: 0141-0229) is a peer-reviewed international scholarly journal in the field of Biology, published by Elsevier Inc. in United States since 1979. The periodical holds a Journal Impact Factor (JIF) of 3.90, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.731 (Q2), an H-index of 171.

The journal enforces rigorous peer evaluation with an average review speed of 6.9周, a publication frequency of Monthly, an annual output of approximately 165 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,088 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Inc.
Publication Language
English
Frequency
Monthly
Founding Year
1979
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d60513be-c236-4053-b7e6-b3a1f7e18669
Database Updated: 2026-10-16